# Transdermal Delivery of Glucosamine to the Synovial Fluid of Male and Female With Knee Osteoarthritis

> **NCT03743896** · PHASE4 · COMPLETED · sponsor: **Lynk Biotechnologies Pte Ltd** · enrollment: 240 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DRUG:** Transdermal Glucosamine Cream

## Key facts

- **NCT ID:** NCT03743896
- **Lead sponsor:** Lynk Biotechnologies Pte Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-18
- **Primary completion:** 2017-03-10
- **Final completion:** 2017-03-10
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2018-11-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03743896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03743896, "Transdermal Delivery of Glucosamine to the Synovial Fluid of Male and Female With Knee Osteoarthritis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03743896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*